Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed Condition

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

January 27, 2022

Study Completion Date

January 27, 2022

Conditions

Healthy Participants

Interventions

DRUG

Bosutinib capsule

500 mg dose of bosutinib capsule contents mixed with applesauce

DRUG

Bosutinib capsule

500 mg dose of bosutinib capsule contents mixed with yogurt

DRUG

Bosutinib capsule

500 mg dose of intact bosutinib capsules

Trial Locations (1)

Pfizer Clinical Research Unit - Brussels, Brussels